Efficacy of Acupuncture in the Management of Primary Dysmenorrhea: A Randomized Controlled Trial

Primary dysmenorrhea is one of the most common gynecologic conditions, affecting 25-50% of women of reproductive age and characterized by severe uterine pain during menstruation, often accompanied by symptoms such as nausea, vomiting, diarrhea, headache, and fatigue. This randomized controlled trial was conducted to evaluate the efficacy of acupuncture in the management of primary dysmenorrhea, a promising therapeutic approach from Traditional Chinese Medicine.

The methodology involved 60 young women (17-23 years) recruited from a residential college in India, all with a history of primary dysmenorrhea for at least one year and regular menstrual cycles. Participants were randomly assigned to two groups: the study group received traditional Chinese acupuncture, while the control group maintained their normal routine without intervention. The acupuncture protocol consisted of 45 sessions distributed over 90 days, with 20 minutes per session, 15 sessions per month, applied at 12 specific points including KI-3, SP-8, ST-25, ST-29, ST-30, ST-36, CV-4, CV-6, BL-62, HT-7, LI-4, and PC-6.

The results demonstrated statistically significant improvements in the acupuncture group compared with the control. Pain intensity, measured by the visual analog scale (VAS), decreased dramatically from 7.29 to 4.43 points in the acupuncture group, while the control group maintained elevated levels (7.17 points). Menstrual cramps also decreased substantially, from 1.90 to 0.70 on a 0-3 scale. In addition, systemic symptoms such as headache, dizziness, diarrhea, mood changes, fatigue, nausea, and vomiting showed significant reductions in the treated group.

The mechanism of action proposed by the researchers is based on the central analgesic effects of acupuncture and its reflex effects on tissues, including changes in blood flow. Previous studies have identified that acupuncture can alter the metabolism of substrates involved in the ascending facilitatory and descending inhibitory pain pathways, stimulating the release of enkephalins and endorphins in specific brain structures. The technique can also regulate neuroendocrine activities of the hypothalamic-pituitary-ovarian axis and promote vasodilation, increasing blood circulation in the target area.

The clinical implications are significant, suggesting that acupuncture can be an effective therapeutic modality for the management of primary dysmenorrhea, offering an alternative free of relevant side effects compared with conventional pharmacologic treatments. The fact that no participant reported adverse effects during the study period reinforces the safety profile of the intervention.

However, the study has important limitations that should be considered when interpreting the results. The sample size calculation was not based on prior or pilot studies, representing a methodologic limitation acknowledged by the authors themselves. In addition, objective measures such as changes in uterine blood flow, biochemical markers, and neurotransmitters were not assessed to elucidate the mechanisms underlying the observed effects. Follow-up of the participants was also limited, not allowing assessment of the persistence of benefits after the end of treatment.

In conclusion, this study provides promising preliminary evidence on the efficacy of acupuncture in the treatment of primary dysmenorrhea, demonstrating clinically significant reductions in pain and associated symptoms. However, future studies with larger samples, longer follow-up, and more objective measures are needed to confirm these findings and better understand the mechanisms of action involved.